[Dawn of the antibiotic era and some consequences for the present]

Jiří Beneš1

  • 1Department of Infectious Diseases, Charles University, Prague. benes.infekce@seznam.cz

Insights

The antibiotic era began in 1910 with arsphenamine, not 1928 with penicillin. Early antibacterial drugs, including chemical compounds like sulphonamides, expanded the definition of antibiotics beyond microbial products.

Area of Science:

  • Microbiology
  • Pharmacology
  • History of Medicine

Context:

  • The traditional view attributes the start of the antibiotic era to Fleming's 1928 penicillin discovery.
  • Modern definitions encompass all antibacterial drugs, including chemical compounds and microbial products.
  • Previous research documented microbial antagonism, leading to early antibacterial agents for superficial infections.

Purpose:

  • To re-evaluate the historical timeline of the antibiotic era.
  • To clarify the definition of antibiotics, including chemical compounds.
  • To highlight the contributions of early researchers and the development of antibacterial drugs.

Summary:

  • The antibiotic era commenced in 1910 with arsphenamine (Salvarsan) by Ehrlich and Hata, not Fleming's penicillin in 1928.
  • The term 'antibiotic' now includes synthetic antibacterial drugs (e.g., sulphonamides) alongside microbial products.
  • Penicillin's medical application resulted from the Oxford team's work, and early enthusiasm led to misinterpretations.

Impact:

  • Redefines the historical starting point of antibiotic therapy.
  • Broadens the understanding of what constitutes an antibiotic.
  • Corrects common misconceptions regarding the discovery and development of antibacterial drugs.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
History of Microbiology01:28

History of Microbiology

Microbiology, a scientific field dedicated to the study of microorganisms, has undergone profound development since its inception in the 17th century. Its history is marked by key discoveries and technological advancements that have shaped our understanding of life at the microscopic level and transformed medicine, agriculture, and industry.Early Foundations of MicrobiologyThe early foundations of microbiology were built on groundbreaking observations and the development of pioneering...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...